drugset / Trial / NCT00092599

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

NCT00092599

Phase 3 Completed 410 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate patients who have coronary heart disease to determine if an investigational drug will further lower cholesterol when taken in combination with an approved cholesterol lowering medication.

Timeline

Start
2003-02
Primary completion
2004-06
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg